essence trial semaglutide Breaking! Phase 3 results just out: 2.4 mg showed significant improvements for adults with #MASH-63% achieved resolution of steatohepatitis with no worsening of fibrosis vs. 34% on placebo at Phase 3 ESSENCE trial: Semaglutide
Description
Manufacturer Suggested Use: Take 1 teaspoon by mouth twice daily and hold for 30-90 seconds before swallowing
We did have patients who lost a moderate amount but we also had patients losing over 15 pounds and even over 20 pounds in the first month
For patients on antithyroid medications, maintain the established monitoring schedule with emphasis on free T4 and T3 levels early in treatment
[DOI] [PubMed] [Google Scholar] 74.Kouvari M, Chrysohoou C, Aggelopoulos P, et al
C., Stefanski, A., & Investigators, S.-
